News Items

  1. Positions Vacant
  2. Announcements
  3. Training 





Haematology Staff Specialist


Locum position available (7 months)

Concord Repatriation and General Hospital, Sydney, NSW
Part time FTE 0.6 (Tue-Thu)
Maternity locum dates: 1 October 2019 - 23 April 2020
The applicant would provide a full range of high quality clinical and laboratory services at Concord Hospital in a supportive team of 8 haematologists. 
Concord Hospital is a tertiary level teaching hospital affiliated with the University of Sydney. The Haeamatology Department provides a full range of clinical haematology services including autologous stem cell transplantation and a busy apheresis unit. 
The position includes providing patients care in outpatient clinics, inpatient wards, provision of consultative advice within the hospital and participation in the after-hours on call roster. 
Dual FRACP/FRCPA preferred with the ability to report bone marrow biopsies and participate in laboratory trainee education.
The department enjoys a collegial and supportive environment with weekly MDT discussions and a vibrant team including three advanced trainees and a thriving clinical trials unit. 
Opportunities for leadership in education and supervision of post-graduate trainees and medical students.
Start date: 1 October 2019. 
Full job description to follow. 

Prof Judith Trotman (HOD)
T:  02 9767 7243



Fellow  in Haematology

Royal Perth Hospital (RPH)
Commencing February 2020
EOI close: Friday 9 August 2019

A position has arisen at Royal Perth Hospital (RPH)  for a Fellow/ Senior Registrar in clinical and laboratory haematology in 2020. The position is suitable for trainees who have completed RACP and RCPA  joint training and wish to develop further expertise in clinical research.

The main role of the position is to coordinate and manage the haematology department clinical trials.  The department is involved with clinical trials across the spectrum of haematology malignancies with a focus on acute myeloid leukaemia, myeloma and lymphoma

Cell and Tissue Therapies of Western Australia (CTTWA) is a facility on site at RPH responsible for stem cell processing and the development of cellular therapies.  The haematology department works closely with CTTWA which  is currently running trials assessing the immunomodulatory effects of mesenchymal stem cells in myelodysplasia, inflammatory bowel disease and organ transplant  rejection. 

CTTWA is also actively involved with a CAR-T cell therapy developmental program which is expected to progress to clinical trials in the next year.

The successful applicant will work closely between the Haematology department and CTTWA in the development and management of these trials.

Other  responsibilities  include a shared service commitment with other fellows and advanced trainee in performing and reporting bone marrow biopsies, reporting laboratory results including peripheral bloods and flow cytometry. Clinical responsibilities include inpatient care, outpatients and a consultative service and an on call commitment.

Please forward an expression of interest and a CV by Friday 9 August 2019 with the names and contact details of 2 referees

Professor Michael Leahy
Head of Haematology,
Royal Perth Hospital,
Perth, Western Australia           

M: 0438 384 482

Download and share the flyer.



Locum position available in northern Sydney
Immediate start required!
Dr Kong, urgently needs a locum to look after clinic patients while on sick leave.
About the role
General haematology practice (mixture of malignant and non malignant). 
Consulting rooms are located at Lindfield and Wahroonga
Immediate start required.
At least 3-4 weeks assignment but it could be longer.
2-3 clinics a week (Mon, Tues, Wed).
4-6 hours per clinic. 
There is some flexibility with days and sites.
Business hours of the rooms is 8am- 4pm
For further details you can contact 
Stephanie Kong
M: 0404 872 874
Email enquiries should be addressed to
Practice manager:
Practice telephone: 02 8090 7507
If you know a colleague who might be interested in the role please download and share the flyer.

Senior Staff Specialist or Staff Specialist (Haematology)

Gold Coast University Hospital, Southport
Permanent full time
Applications close 27 May 2019

Provide a full range of high quality tertiary level medical services for Haematology for the Gold Coast Hospital and Health Service (GCHHS). Provide clinical care to patients within the inpatient setting (ward and day unit) and outpatient clinics inclusive of after-hours (on call and recall service) to clinically manage the provision, development and maintenance of an effective, efficient and equitable service to ensure appropriate patient care. Provide leadership and development in the specialty area and provide training, education and supervision to advanced trainees, junior medical staff and other health care members. Work collaboratively across all departments within GCHHS, in particularly with Oncology, the Emergency Department and Pathology Queensland to provide a comprehensive haematology service. 

Download the job description.

Apply here:






  1. HSANZ Queensland Branch Haematology Travel Grants 2019 (Applications close date extended to Friday 7 June 2019)
  2. Maddie Riewoldt’s Vision release 2019 Granting Round Information (Call for grants close 1 June 2019
  3. The Victorian Cancer Cytogenetics ServiceInterim arrangements for clinical support



HSANZ QLD Haematology Travel Grants 2019


Haematology Trainees, Nurses and Scientists

Download and share the flyer with your Queensland haematology colleagues.

Application Close Date Extended to Friday 7 June 2019


The Queensland Branch of the HSANZ is pleased to call for applications for travel grants to be taken up in 2019.

The HSANZ QLD Branch Travel Grant is designed to assist members to attend and present at a local or international scientific meeting of their choice. Applicants must plan to submit an abstract to that meeting.

Open to trainees, nurses and scientists, applicants must be members of HSANZ, or have applied to become members two working days before applications close on Friday 7 June 2019. Membership forms are available on the HSANZ website.

Each travel grant has a maximum value of $2500 and is to be used toward paying meeting registration, economy airfares and/or accommodation costs. The grant cannot be used in conjunction with other grants or pharmaceutical company funding to attend the proposed conference.

To be considered, applicants should provide the following:

  1. A covering letter outlining the proposed research project with a synopsis of what is hoped to be achieved and the name of the conference you would like to attend. (Max. 1 pages).
  2. A full curriculum vitae, including details of undergraduate training, awards and prizes, postgraduate training and experience, publications and presentations at state, national and international meetings. (Max. 4 pages)

Travel Grant Award Criteria
The award of the HSANZ QLD Branch Travel Grants will be based on the following criteria:

  1. Proposed research project
  2. Past academic record
  3. Publications and presentations at meetings 

Note: Preference will be given applicants who have not received prior Qld Branch Travel Grants

Applications are be addressed to:

Dr Steven Lane
HSANZ Councillor
Cancer Care Services, RBWH
QIMR Berghofer Medical Research

Applications are to be emailed to:
Julie Blake:

HSANZ QLD Branch Travel Grants 2019  


Applications Close Date Extended to Friday 7 June 2019

Only successful applicants will be contacted.
The award will provide reimbursement for expenses up to the value of $2500 AUD.
A copy of a tax invoice or receipts will be required for reimbursement.

Download and share the flyer with your Queensland haematology colleagues.





Maddie Riewoldt’s Vision release 2019 Granting Round Information

For the first time, Maddie’s Vision will offer funding opportunities in 3 separate categories:

• Grants-In-Aid, to support research projects into the causes and treatment of Bone Marrow Failure (BMF) - $50,000 AUD per annum for up to two years

• Fellowships, to support research into the causes and treatment of BMF - $100,000 AUD per annum for up to three years

• Programs, high clinical impact, multidisciplinary investigators/multiple site research collaboration of international standard - $1 million AUD to be awarded over a minimum three and maximum of five year period

The Call for Grants will be offered twice a year for Grants-In-Aid (May and Nov), and once a year for Fellowships (May) and Programs (November).

We seek expressions of interest from appropriately qualified scientific or medical researchers and research that is specifically directed towards finding a cure for both congenital and acquired BMF syndromes.

Further details and application templates are available for download on our website.

The Call for Grants will be offered twice a year for Grants-In-Aid (May and Nov), and once a year for Fellowships (May) and Programs (November)

We seek expressions of interest from appropriately qualified scientific or medical researchers and research that is specifically directed towards finding a cure for both congenital and acquired BMF syndromes.  

For detailed information, please download our Granting Round Information Document.

Application Templates are available for download:

  1. GIA EOI Application
  2. GIA Full Application
  3. Program EOI Application
  4. Program Full Application
  5. Fellowship Application 

Please direct any enquiries or questions to Dr Simonne Neil


First round closes 5pm AEST 1st June 2019




Important Announcement for Victoria

The Victorian Cancer Cytogenetics Service,
St Vincent’s Hospital Melbourne

Interim arrangements for clinical support

As the longstanding provider of the Victorian Cancer Cytogenetics Service, St Vincent’s Hospital Melbourne is committed to continuing to provide this well-regarded service and maintain the quality of the service following the resignation of the Medical Director. 

We would like to inform you of the interim arrangements for clinical support while we recruit to the ongoing position. 

The following arrangements will be in place from 1 March 2019.

A clinical consultant with expertise in clinical and laboratory haematology is being engaged to provide clinical support and medical liaison to referrers.

Service Operation Hours
There is no change to the service hours of operation and afterhours arrangement will continue for management of clinically urgent samples.

For enquiries please contact:
Fran O’Malley, Principal Scientist,
Victorian Cancer Cytogenetics Service,
Telephone: +61 3 9231 4151

After hours
For management of clinically urgent samples after hours:
Telephone +61 3 9231 2211 ( St Vincent’s switch) and ask to be connected to  Fran O’Malley’s mobile phone.

Download and share the flyer with colleagues.





Expressions of Interest


Speakers required for NEW on-line training program for Haematology trainees

We are looking for speakers across all states to deliver an innovative online clinical training program for haematology trainees. Trainees have highlighted a gap in clinical training. This program aims to complement pathology training by focusing on clinical aspects of haematological disease. The program is endorsed by HSANZ and the CJCT. We have a steering committee including state training co-ordinators and we have partnered with MD briefcase, a company that delivers online educational content.

If interested, please contact:
Dr Nada Hamad
Please identify your area of interest or expertise.





Vale Professor Francesco Lo Coco 

It is with great sadness that we must advise the haematology community in Australia and New Zealand of the tragic death of Professor Francesco Lo Coco on 3 March 2019 at the age of 63.

Internationally renowned for his numerous achievements in acute leukaemia, including as recipient of the José Carreras Award, Prof Lo Coco was especially recognised for his inspirational clinical and laboratory research in acute promyelocytic leukaemia.

Prof Lo Coco led the GIMEMA group’s APL clinical trial program which pioneered the AIDA-based protocols, and subsequently demonstrated the superiority of a chemotherapy-free ATRA and arsenic protocol for patients with standard-risk APL.

Together with Miguel Sanz, he was the driving force behind the highly successful quadrennial International APL Symposia and the recently published update of the European LeukemiaNet guidelines on the diagnosis and management of APL. Prof Lo Coco’s work benefitted haematologists and patients enormously, and he leaves behind a great legacy in what was once an almost uniformly fatal disease.

Francesco was a personal friend to many Australian and New Zealand haematologists. He will be remembered for his charm, generosity, brilliance and compassion, and he will be greatly missed.

Peter Mollee
Scientific Advisory Committee
Australasian Leukaemia & Lymphoma Group 

William Stevenson
Haematology Society of Australia and New Zealand

Harry Iland
Principal Investigator
ALLG APL trials
Australasian Leukaemia & Lymphoma Group

Share the print version of this notice with colleagues


Last Updated: 28 May 2019